Histone deacetylase, proteasome, and heat shock protein inhibitors for the treatment of lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Volumn 5, Issue 12 Suppl 6, 2010, Pages

  Ramalingam, Suresh S ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEAT SHOCK PROTEIN; HISTONE DEACETYLASE; PROTEASOME;

ARTICLE; CHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG ANTAGONISM; HUMAN; LUNG TUMOR; METABOLISM;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HEAT-SHOCK PROTEINS; HISTONE DEACETYLASES; HUMANS; LUNG NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX;

MLCS; MLOWN;

EID: 79952456656     PISSN: None     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01.jto.0000391365.56258.16     Document Type: Article

References (0)